Company: GMRE
Filing Date: 2025-11-14
Form Type: 424B5
Source: 0001104659-25-112543
Chunk: 14

Company: Global Medical REIT Inc.
Filing Date: 2025-11-14
Form: 424B5
Chunk 14
---
.”

Risks Related to This Offering and Our Business

Our Series B Preferred Stock has not been rated by a nationally recognized statistical rating organization.

We have not sought to obtain a rating for our
Series B Preferred Stock from a nationally recognized statistical rating organization. However, no assurance can be given that one
or more nationally recognized statistical rating organizations might not independently determine to issue such a rating or that such a
rating, if issued, would not adversely affect the market price of our Series B Preferred Stock. In addition, we may elect in the
future to obtain a rating of our Series B Preferred Stock, which could adversely impact the market price of our Series B Preferred
Stock. Ratings only reflect the views of the rating agency or agencies issuing the ratings, and such ratings could be revised downward
or withdrawn entirely at the discretion of the issuing rating agency if in its judgment circumstances so warrant. Any such downward revision
or withdrawal of a rating could have an adverse effect on the market price of our Series B Preferred Stock.

Shares of our Series B Preferred Stock are newly issued securities with no established trading market, which may negatively affect their market value and your ability to transfer or sell your shares. We intend to apply to list our Series B Preferred Stock on the NYSE, but we cannot assure you that the listing will be approved or that a trading market will develop or be sustained.

Shares of our Series B Preferred Stock are
newly issued securities with no established trading market. We intend to apply to list our Series B Preferred Stock on the NYSE,
but we cannot assure you that our Series B Preferred Stock will be approved for listing. An active trading market on the NYSE for
our Series B Preferred Stock may not develop or, even if it develops, may not be sustained, in which case the trading price of our
Series B Preferred Stock could be adversely affected.

The market price and trading volume of our Series B Preferred Stock may fluctuate substantially and be volatile due to numerous factors beyond our control.

The market price of our Series B Preferred
Stock may be highly volatile and be subject to wide fluctuations. In addition, the trading volume in our Series B Preferred Stock
may fluctuate and cause significant price variations to occur. If the market price of our Series B Preferred Stock declines significantly,
you may be unable to resell your shares at or above the public offering price. We cannot assure you that the market price of our Series B
Preferred Stock will not fluctuate or decline significantly in the future. Some of the factors that could negatively